Myriad Genetics Inc.
Company Snapshot
Founded: 1991
Entity Type: Public
Employees: 2,700
Region: U.S.
Revenue: $837.6 Millions
Revenue Year: 2024
Headquarter: Salt Lake City, Utah, U.S.
Key Geographics: U.S., Rest of the World
Corporate Address: 322 North 2200 West, Salt Lake City, Utah 84116, U.S. Tel. +1-801-584-3600 www.myriad.com
Company Overview
Myriad Genetics, Inc. is a genetic testing and precision medicine established in 1991 and headquartered in Utah, U.S. The company’s test kits assess the disease risk, predict progression, and guide treatment decisions across various medical fields. By providing critical genetic insights, we help individuals manage their health and enable healthcare providers to improve disease detection, treatment, and prevention, ultimately reducing healthcare costs.
Myriad testing focuses on gene expression to evaluate disease risk, medication responses, and progression likelihood and offers prenatal insights
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Hereditary Cancer : MyRisk, BRACAnalysis, BRACAnalysis CDx
- Tumor Profiling : MyChoice CDx, Prolaris, EndoPredict
- Prenatal : Foresight, Prequel, SneakPeek
- Pharmacogenomics : GeneSight
Applications/End User Industries
- Healthcare
- Molecular Diagnostics
- Pharmaceuticals
- Life Sciences
BCC Research Beacon 